駆虫薬の世界市場2020-2030:産業分析、規模、シェア、成長、動向、予測

• 英文タイトル:Anthelmintic Drugs Market (Drug Class: Benzimidazoles, Piperazine, and Others; Route of Administration: Oral and Injectable; Application: Human [Parenchymal Neurocysticercosis and Gastrointestinal Infections] and Animal; Target Pathogen: Ascaris Lumbricoides [Roundworm], Trichuris Trichiura [Whipworm], Enterobius Vermicularis [Pinworm], Ancylostoma Duodenale [Hookworm], and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, and Veterinary Hospitals & Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

Anthelmintic Drugs Market (Drug Class: Benzimidazoles, Piperazine, and Others; Route of Administration: Oral and Injectable; Application: Human [Parenchymal Neurocysticercosis and Gastrointestinal Infections] and Animal; Target Pathogen: Ascaris Lumbricoides [Roundworm], Trichuris Trichiura [Whipworm], Enterobius Vermicularis [Pinworm], Ancylostoma Duodenale [Hookworm], and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, and Veterinary Hospitals & Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030「駆虫薬の世界市場2020-2030:産業分析、規模、シェア、成長、動向、予測」(市場規模、市場予測)調査レポートです。• レポートコード:TMR2008038
• 出版社/出版日:Transparency Market Research / 2020年5月
• レポート形態:英文、PDF、ページ数はお問い合わせください。
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥602,680 (USD5,795)▷ お問い合わせ
  Multi User¥914,680 (USD8,795)▷ お問い合わせ
  Corporate License¥1,226,680 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは駆虫薬の世界市場について調査・分析し、序文、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、薬物クラス別(ベンズイミダゾール、ピペラジン、その他)分析、投与経路別(経口、注射)分析、用途別(人間、動物)分析、標的病原体別(回虫、鞭虫、蟯虫、ズビニ鉤虫、その他)分析、流通チャンネル別(病院薬局、小売薬局、オンライン薬局、獣医薬局、獣医病院・診療所)分析、地域別(ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などを含め、以下の構成でご提供いたします。
・序文
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・駆虫薬の世界市場:薬物クラス別(ベンズイミダゾール、ピペラジン、その他)
・駆虫薬の世界市場:投与経路別(経口、注射)
・駆虫薬の世界市場:用途別(人間、動物)
・駆虫薬の世界市場:標的病原体別(回虫、鞭虫、蟯虫、ズビニ鉤虫、その他)
・駆虫薬の世界市場:流通チャンネル別(病院薬局、小売薬局、オンライン薬局、獣医薬局、獣医病院・診療所)
・駆虫薬の世界市場:地域別(ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Anthelmintic Drugs Market – Scope of the Report

TMR’s report on the global anthelmintic drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period 2020 to 2030 The report provides the overall revenue of the global anthelmintic drugs market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global anthelmintic drugs market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global anthelmintic drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global anthelmintic drugs market.

The report delves into the competition landscape of the global anthelmintic drugs market. Key players operating in the global anthelmintic drugs market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global anthelmintic drugs market report.

Key Questions Answered in Anthelmintic Drugs Market Report

What is the sales/revenue generated by the global anthelmintic drugs market across all the regions during the forecast period?
What are the key trends in the global anthelmintic drugs market?
What are the major drivers, restraints, and opportunities in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2030 and which drug class will expand at the fastest CAGR during the forecast period?
Anthelmintic Drugs Market – Research Objectives and Research Approach

The comprehensive report on the global anthelmintic drugs market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global anthelmintic drugs market. It is followed by market introduction, market dynamics, and an overview of the global anthelmintic drugs market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the anthelmintic drugs market. The next section of the global anthelmintic drugs market report highlights the USPs, which include epidemiology of helminthic infections across globe, key industry events (product launches, approvals, acquisitions, mergers, collaborations, etc.), and impact of COVID-19 on the anthelmintic drugs market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key anthelmintic drugs manufacturers has been mapped to ascertain the size of the global anthelmintic drugs market in terms of value. The forecast presented here assesses the total revenue generated in the anthelmintic drugs market. In order to provide an accurate forecast, we initiated by sizing up the current anthelmintic drugs market with the help of the parent market.

The report analyzes the global anthelmintic drugs market in terms of drug class, route of administration, application, target pathogen, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global anthelmintic drugs market.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Anthelmintic Drugs Market

4. Market Overview

4.1. Introduction

4.1.1. Market Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Anthelmintic Drugs Market Analysis and Forecast, 2018–2030

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Epidemiology of Helminthic Infections

5.2. Key Industry Events (Product Launch, Approval, Acquisition, Merger, Collaboration, etc.)

5.3. Impact of COVID-19 on Anthelmintic Drugs Market

6. Global Anthelmintic Drugs Market Analysis and Forecast, by Drug Class

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030

6.3.1. Benzimidazoles

6.3.2. Piperazine

6.3.3. Others

6.4. Market Attractiveness Analysis, by Drug Class

7. Global Anthelmintic Drugs Market Analysis and Forecast, by Route of Administration

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030

7.3.1. Oral

7.3.2. Injectable

7.4. Market Attractiveness Analysis, by Route of Administration

8. Global Anthelmintic Drugs Market Analysis and Forecast, by Application

8.1. Introduction & Definition

8.2. Key Findings / Developments

8.3. Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030

8.3.1. Human

8.3.1.1. Parenchymal Neurocysticercosis

8.3.1.2. Gastrointestinal Infections

8.3.2. Animal

8.4. Market Attractiveness Analysis, by Application

9. Global Anthelmintic Drugs Market Analysis and Forecast, by Target Pathogen

9.1. Introduction & Definition

9.2. Key Findings / Developments

9.3. Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030

9.3.1. Ascaris Lumbricoides (Roundworm)

9.3.2. Trichuris Trichiura (Whipworm

9.3.3. Enterobius Vermicularis (Pinworm)

9.3.4. Ancylostoma Duodenale (Hookworm)

9.3.5. Others

9.4. Market Attractiveness Analysis, by Target Pathogen

10. Global Anthelmintic Drugs Market Analysis and Forecast, by Distribution Channel

10.1. Introduction & Definition

10.2. Key Findings / Developments

10.3. Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030

10.3.1. Hospital Pharmacies

10.3.2. Retail Pharmacies

10.3.3. Online Pharmacies

10.3.4. Veterinary Pharmacies

10.3.5. Veterinary Hospitals & Clinics

10.4. Market Attractiveness Analysis, by Distribution Channel

11. Global Anthelmintic Drugs Market Analysis and Forecast, by Region

11.1. Key Findings

11.2. Anthelmintic Drugs Market Value Forecast, by Region

11.2.1. Europe

11.2.2. Europe

11.2.3. Asia Pacific

11.2.4. Latin America

11.2.5. Middle East & Africa

11.3. Market Attractiveness Analysis, by Region

12. North America Anthelmintic Drugs Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.2. North America Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030

12.2.1. Benzimidazoles

12.2.2. Piperazine

12.2.3. Others

12.3. North America Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030

12.3.1. Oral

12.3.2. Injectable

12.4. North America Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030

12.4.1. Human

12.4.1.1. Parenchymal Neurocysticercosis

12.4.1.2. Gastrointestinal Infections

12.4.2. Animal

12.5. North America Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030

12.5.1. Ascaris Lumbricoides (Roundworm)

12.5.2. Trichuris Trichiura (Whipworm

12.5.3. Enterobius Vermicularis (Pinworm)

12.5.4. Ancylostoma Duodenale (Hookworm)

12.5.5. Others

12.6. North America Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030

12.6.1. Hospital Pharmacies

12.6.2. Retail Pharmacies

12.6.3. Online Pharmacies

12.6.4. Veterinary Pharmacies

12.6.5. Veterinary Hospitals & Clinics

12.7. North America Anthelmintic Drugs Market Value Forecast, by Country, 2018–2030

12.7.1. U.S.

12.7.2. Canada

12.8. North America Anthelmintic Drugs Market Attractiveness Analysis

12.8.1. By Drug Class

12.8.2. By Route of Administration

12.8.3. By Application

12.8.4. By Target Pathogen

12.8.5. By Distribution Channel

12.8.6. By Country

13. Europe Anthelmintic Drugs Market Analysis and Forecast

13.1. Introduction

13.1.1. Key Findings

13.2. Europe Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030

13.2.1. Benzimidazoles

13.2.2. Piperazine

13.2.3. Others

13.3. Europe Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030

13.3.1. Oral

13.3.2. Injectable

13.4. Europe Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030

13.4.1. Human

13.4.1.1. Parenchymal Neurocysticercosis

13.4.1.2. Gastrointestinal Infections

13.4.2. Animal

13.5. Europe Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030

13.5.1. Ascaris Lumbricoides (Roundworm)

13.5.2. Trichuris Trichiura (Whipworm

13.5.3. Enterobius Vermicularis (Pinworm)

13.5.4. Ancylostoma Duodenale (Hookworm)

13.5.5. Others

13.6. Europe Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030

13.6.1. Hospital Pharmacies

13.6.2. Retail Pharmacies

13.6.3. Online Pharmacies

13.6.4. Veterinary Pharmacies

13.6.5. Veterinary Hospitals & Clinics

13.7. Europe Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030

13.7.1. Germany

13.7.2. U.K.

13.7.3. France

13.7.4. Spain

13.7.5. Italy

13.7.6. Rest of Europe

13.8. Europe Anthelmintic Drugs Market Attractiveness Analysis

13.8.1. By Drug Class

13.8.2. By Route of Administration

13.8.3. By Application

13.8.4. By Target Pathogen

13.8.5. By Distribution Channel

13.8.6. By Country/Sub-region

14. Asia Pacific Anthelmintic Drugs Market Analysis and Forecast

14.1. Introduction

14.1.1. Key Findings

14.2. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030

14.2.1. Benzimidazoles

14.2.2. Piperazine

14.2.3. Others

14.3. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030

14.3.1. Oral

14.3.2. Injectable

14.4. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030

14.4.1. Human

14.4.1.1. Parenchymal Neurocysticercosis

14.4.1.2. Gastrointestinal Infections

14.4.2. Animal

14.5. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030

14.5.1. Ascaris Lumbricoides (Roundworm)

14.5.2. Trichuris Trichiura (Whipworm

14.5.3. Enterobius Vermicularis (Pinworm)

14.5.4. Ancylostoma Duodenale (Hookworm)

14.5.5. Others

14.6. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030

14.6.1. Hospital Pharmacies

14.6.2. Retail Pharmacies

14.6.3. Online Pharmacies

14.6.4. Veterinary Pharmacies

14.6.5. Veterinary Hospitals & Clinics

14.7. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030

14.7.1. China

14.7.2. Japan

14.7.3. India

14.7.4. Australia & New Zealand

14.7.5. Rest of Asia Pacific

14.8. Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis

14.8.1. By Drug Class

14.8.2. By Route of Administration

14.8.3. By Application

14.8.4. By Target Pathogen

14.8.5. By Distribution Channel

14.8.6. By Country/Sub-region

15. Latin America Anthelmintic Drugs Market Analysis and Forecast

15.1. Introduction

15.1.1. Key Findings

15.2. Latin America Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030

15.2.1. Benzimidazoles

15.2.2. Piperazine

15.2.3. Others

15.3. Latin America Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030

15.3.1. Oral

15.3.2. Injectable

15.4. Latin America Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030

15.4.1. Human

15.4.1.1. Parenchymal Neurocysticercosis

15.4.1.2. Gastrointestinal Infections

15.4.2. Animal

15.5. Latin America Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030

15.5.1. Ascaris Lumbricoides (Roundworm)

15.5.2. Trichuris Trichiura (Whipworm

15.5.3. Enterobius Vermicularis (Pinworm)

15.5.4. Ancylostoma Duodenale (Hookworm)

15.5.5. Others

15.6. Latin America Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030

15.6.1. Hospital Pharmacies

15.6.2. Retail Pharmacies

15.6.3. Online Pharmacies

15.6.4. Veterinary Pharmacies

15.6.5. Veterinary Hospitals & Clinics

15.7. Latin America Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030

15.7.1. Brazil

15.7.2. Mexico

15.7.3. Rest of Latin America

15.8. Latin America Anthelmintic Drugs Market Attractiveness Analysis

15.8.1. By Drug Class

15.8.2. By Route of Administration

15.8.3. By Application

15.8.4. By Target Pathogen

15.8.5. By Distribution Channel

15.8.6. By Country/Sub-region

16. Middle East & Africa Anthelmintic Drugs Market Analysis and Forecast

16.1. Introduction

16.1.1. Key Findings

16.2. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018–2030

16.2.1. Benzimidazoles

16.2.2. Piperazine

16.2.3. Others

16.3. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018–2030

16.3.1. Oral

16.3.2. Injectable

16.4. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Application, 2018–2030

16.4.1. Human

16.4.1.1. Parenchymal Neurocysticercosis

16.4.1.2. Gastrointestinal Infections

16.4.2. Animal

16.5. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018–2030

16.5.1. Ascaris Lumbricoides (Roundworm)

16.5.2. Trichuris Trichiura (Whipworm

16.5.3. Enterobius Vermicularis (Pinworm)

16.5.4. Ancylostoma Duodenale (Hookworm)

16.5.5. Others

16.6. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018–2030

16.6.1. Hospital Pharmacies

16.6.2. Retail Pharmacies

16.6.3. Online Pharmacies

16.6.4. Veterinary Pharmacies

16.6.5. Veterinary Hospitals & Clinics

16.7. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018–2030

16.7.1. GCC Countries

16.7.2. South Africa

16.7.3. Rest of Middle East & Africa

16.8. Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis

16.8.1. By Drug Class

16.8.2. By Route of Administration

16.8.3. By Application

16.8.4. By Target Pathogen

16.8.5. By Distribution Channel

16.8.6. By Country/Sub-region

17. Competitive Landscape

17.1. Market Player – Competition Matrix (By Tier and Size of companies)

17.2. Company Profiles

17.2.1. Novartis AG

17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

17.2.1.2. Financial Overview

17.2.1.3. Product Portfolio

17.2.1.4. Strategic Overview

17.2.1.5. SWOT Analysis

17.2.2. Zoetis, Inc.

17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

17.2.2.2. Financial Overview

17.2.2.3. Product Portfolio

17.2.2.4. Strategic Overview

17.2.2.5. SWOT Analysis

17.2.3. Amneal Pharmaceuticals Inc.

17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

17.2.3.2. Financial Overview

17.2.3.3. Product Portfolio

17.2.3.4. Strategic Overview

17.2.3.5. SWOT Analysis

17.2.4. Cipla Inc.

17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

17.2.4.2. Financial Overview

17.2.4.3. Product Portfolio

17.2.4.4. Strategic Overview

17.2.4.5. SWOT Analysis

17.2.5. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)

17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

17.2.5.2. Financial Overview

17.2.5.3. Product Portfolio

17.2.5.4. Strategic Overview

17.2.5.5. SWOT Analysis

17.2.6. Sun Pharmaceutical Industries Ltd

17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

17.2.6.2. Financial Overview

17.2.6.3. Product Portfolio

17.2.6.4. Strategic Overview

17.2.6.5. SWOT Analysis

17.2.7. GlaxoSmithKline plc

17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

17.2.7.2. Financial Overview

17.2.7.3. Product Portfolio

17.2.7.4. Strategic Overview

17.2.7.5. SWOT Analysis

17.2.8. Bayer AG

17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

17.2.8.2. Financial Overview

17.2.8.3. Product Portfolio

17.2.8.4. Strategic Overview

17.2.8.5. SWOT Analysis

17.2.9. Merck & Co. Inc. (Intervet Inc.)

17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

17.2.9.2. Financial Overview

17.2.9.3. Product Portfolio

17.2.9.4. Strategic Overview

17.2.9.5. SWOT Analysis

17.2.10. Boehringer Ingelheim International GmbH

17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

17.2.10.2. Financial Overview

17.2.10.3. Product Portfolio

17.2.10.4. Strategic Overview

17.2.10.5. SWOT Analysis

List of Tables

Table 01: Europe Anthelmintic Drugs Market - Prevalence

Table 02: Europe Anthelmintic Drugs Market - Prevalence

Table 03: Global Anthelmintic Drugs Market Forecast, by Drug Class

Table 04: Global Anthelmintic Drugs Market Forecast, by Route of Administration

Table 05: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2020–2030

Table 06: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2020–2030

Table 07: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018-2030

Table 08: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 09: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Region, 2018-2030

Table 10: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country, 2018?2030

Table 11: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018?2030

Table 12: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018?2030

Table 13: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018?2030

Table 14: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018?2030

Table 15: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018?2030

Table 16: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018?2030

Table 17: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018?2030

Table 18: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018?2030

Table 19: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route Of Administration, 2018?2030

Table 20: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018?2030

Table 21: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018?2030

Table 22: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018?2030

Table 23: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018?2030

Table 24: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 25: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

Table 26: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route Of Administration, 2018–2030

Table 27: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 28: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human Application, 2018–2030

Table 29: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018–2030

Table 30: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 31: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 32: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

Table 33: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 34: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 35: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018–2030

Table 36: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018–2030

Table 37: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 38: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 39: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018–2030

Table 40: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018–2030

Table 41: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 42: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018–2030

Table 43: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018–2030

Table 44: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030


• 英文レポート名:Anthelmintic Drugs Market (Drug Class: Benzimidazoles, Piperazine, and Others; Route of Administration: Oral and Injectable; Application: Human [Parenchymal Neurocysticercosis and Gastrointestinal Infections] and Animal; Target Pathogen: Ascaris Lumbricoides [Roundworm], Trichuris Trichiura [Whipworm], Enterobius Vermicularis [Pinworm], Ancylostoma Duodenale [Hookworm], and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, and Veterinary Hospitals & Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030
• 日本語訳:駆虫薬の世界市場2020-2030:産業分析、規模、シェア、成長、動向、予測
• レポートコード:TMR2008038お問い合わせ(見積依頼・ご注文・質問)